237 related articles for article (PubMed ID: 35039491)
1. The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.
Morgan SM; Tanizawa H; Caruso LB; Hulse M; Kossenkov A; Madzo J; Keith K; Tan Y; Boyle S; Lieberman PM; Tempera I
Nat Commun; 2022 Jan; 13(1):187. PubMed ID: 35039491
[TBL] [Abstract][Full Text] [Related]
2. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
[TBL] [Abstract][Full Text] [Related]
3. PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.
Lupey-Green LN; Moquin SA; Martin KA; McDevitt SM; Hulse M; Caruso LB; Pomerantz RT; Miranda JL; Tempera I
Virology; 2017 Jul; 507():220-230. PubMed ID: 28456021
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1.
Hulse M; Caruso LB; Madzo J; Tan Y; Johnson S; Tempera I
PLoS Pathog; 2018 Nov; 14(11):e1007394. PubMed ID: 30395643
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site.
Chen HS; Martin KA; Lu F; Lupey LN; Mueller JM; Lieberman PM; Tempera I
J Virol; 2014 Feb; 88(3):1703-13. PubMed ID: 24257606
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
Martin KA; Lupey LN; Tempera I
J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
[TBL] [Abstract][Full Text] [Related]
8. The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC.
Maestri D; Napoletani G; Kossenkov A; Preston-Alp S; Caruso LB; Tempera I
Nucleic Acids Res; 2023 Dec; 51(22):12092-12110. PubMed ID: 37889078
[TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.
Ding W; Wang C; Narita Y; Wang H; Leong MML; Huang A; Liao Y; Liu X; Okuno Y; Kimura H; Gewurz B; Teng M; Jin S; Sato Y; Zhao B
J Virol; 2022 Sep; 96(18):e0073922. PubMed ID: 36094314
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome.
Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
[TBL] [Abstract][Full Text] [Related]
11. Chromatin Structure of Epstein-Barr Virus Latent Episomes.
Lieberman PM
Curr Top Microbiol Immunol; 2015; 390(Pt 1):71-102. PubMed ID: 26424644
[TBL] [Abstract][Full Text] [Related]
12. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
13. Occupancy of chromatin organizers in the Epstein-Barr virus genome.
Holdorf MM; Cooper SB; Yamamoto KR; Miranda JJ
Virology; 2011 Jun; 415(1):1-5. PubMed ID: 21550623
[TBL] [Abstract][Full Text] [Related]
14. Three-Dimensional Chromatin Structure of the EBV Genome: A Crucial Factor in Viral Infection.
Caruso LB; Maestri D; Tempera I
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243174
[TBL] [Abstract][Full Text] [Related]
15. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
16. Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection.
Tsai K; Chan L; Gibeault R; Conn K; Dheekollu J; Domsic J; Marmorstein R; Schang LM; Lieberman PM
J Virol; 2014 Dec; 88(24):14350-63. PubMed ID: 25275136
[TBL] [Abstract][Full Text] [Related]
17. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1.
Tempera I; Deng Z; Atanasiu C; Chen CJ; D'Erme M; Lieberman PM
J Virol; 2010 May; 84(10):4988-97. PubMed ID: 20219917
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
